The biotechnology company Aker BioMarine has entered into an agreement with a leading Omega-3 distributor for sale of Aker BioMarine’s krill oil in the US dietary supplement market.
Aker BioMarine has signed an agreement for sale of Aker BioMarine’s krill oil with Jedwards International Inc., a leading Omega-3 distributor in the US market. Jedwards holds an estimated 25-30 percent market share in the US. The agreement gives Aker BioMarine access to an established customer base and a major distribution network.
“We are experiencing a great deal of market interest in krill oil internationally, and the agreement with Jedwards gives us strong sales and distribution clout in the important US market,” says Aker BioMarine’s President and CEO Helge Midttun.
Aker BioMarine’s krill oil contains high concentrations of marine phospholipids, Omega-3 bound to phospholipids, and the naturally occurring antioxidant astaxanthin. These are bioactive ingredients with documented health benefits.
Last week, Aker BioMarine communicated that the biotechnology company had entered into an agreement with Life Europe AB that secures broad distribution of its krill oil products in the Norwegian, Swedish, and Finnish health food markets. The agreement is unique in that only two participants are involved in the long value chain spanning from sustainable harvesting of live krill in Antarctic waters through sale of high-quality krill oil to consumers.
“With this agreements signed for the US and Nordic markets, we are ready to launch the healthiest the oceans have to offer in a ruby-red capsule,” says Aker BioMarine President and CEO Helge Midttun.